Tag: Vertess

LITTLETON, Colo. – Vivos Therapeutics, a medical technology company that makes oral appliances for patients suffering from mild-to-moderate obstructive sleep apnea and snoring in adults, has signed a distribution agreement with Lincare.  The agreement follows a successful a distribution pilot with Lincare and marks an important milestone in Vivos’ strategy to engage with leading durable medical equipment companies in the United States. Lincare will have a six-month exclusive deal...

FORTH WORTH, Texas – Vertess has closed five major health care transactions in the third quarter of 2023 with a total value of $75 million. The transactions were in various health care verticals. "At the end of 2022 and early 2023, we saw a sharp decline in the pace of M&A activity,” said Brad Smith, managing director. “We continued to push forward and remain patient. We are pleased for our clients that our perseverance with buyers resulted in several successes." Vertess sees signs...

DALLAS – While uncertainty in the broader economy has caused a slowdown in M&A, when buyers and sellers know what they want, deals are getting done, said experts at Medtrade on Tuesday.  “Why do you want to transact?” asked Brad Smith, managing director/partner at Vertess. “Why do you want to buy or sell? (If you’re selling), give a buyer enough information so they can make an educated decision. Make it a conversation. Have calls; get to know these people.”  Smith...

YARMOUTH, Maine – Industry analysts see steady deal-making in 2023, with a variety of companies making buys in both typically hot markets like respiratory and newly hot markets like repairs, but with more of a focus on due diligence.  “I think the interest is at both the national level, as well as the larger regionals, aggressively pursuing acquisitions,” said Pat Clifford, managing director, home medical equipment, for The Braff Group. “There is acquisition appetite...

WASHINGTON – CMS should bolster its oversight of manufacturer-submitted average sales price (ASP) data to ensure accurate Part B drug payments, according to a new report from the Office of Inspector General.   Due to invalid or missing ASP data, CMS could not calculate an ASP-based payment amount for 8% of drug codes at least once between 2016-20, the OIG found.  “CMS was unable to calculate an ASP-based payment amount for several reasons, including that (1)...

FORT WORTH, Texas – Vertess recently hired Jonathan Hadley as their newest managing director. Hadley has experience in the medical device space after leading and growing MSC Biomedical, a large medical device service organization in North America, where he served in various roles, including CEO. At MSC Biomedical, Hadley was able to work directly with medical device manufacturers, HME providers and former competitors as he executed upon a national network acquisition M+A strategy. "I have been...

FORT WORTH, Texas – Vertess has promoted three managing directors to partner: Rachel Boynton, Anna Elliott and Robert Villalobos. Boynton joined VERTESS in 2018 as a managing director providing M&A advisory and consulting services to the intellectual and developmental disability (I/DD), behavioral health and related health care markets. Elliott, who joined the firm earlier this year, has experience in high-growth, health care technologies, including artificial intelligence and machine...

Coming off a “crazy” year of dealmaking in 2021, the first quarter of 2022 was bound to be slower, driven in part by larger world issues like inflation and the war in Ukraine, says Brad Smith, managing director and partner at Vertess.  But deals are still getting done, as interest remains high in HME from both strategic players and institutional buyers, he said.  “There are fewer headwinds than previous years,” he said. “There’s more certainty and...

FORT WORTH, Texas – Vertess closed three transactions in the first quarter of 2022, including the sale of California-based Brannons Medical to AdaptHealth.  “Brannons was a staple in the San Jose community for 20-plus years,” said Robert Villalobos, managing director and deal lead for Vertess. “With the continued appetite for respiratory providers, it comes as no surprise the family run business was a desirable acquisition.”  Vertess also represented...

FORT WORTH, Texas - Now is the time for HME providers to start looking at artificial intelligence (AI) and machine learning to improve quality of care without increasing costs, says Anna Elliot, a new managing director and partner at Vertess.  Here’s what Elliot, who specializes in high-growth, health care technologies, had to say about how medtech can be used and why you need it.  HME News: How much is machine learning and AI driving the growth in health care right now?  Anna...